Evaluation of the Performance of the Doraldo-Castelletti Scale in Supporting the Neurologist's Decision to Refer Migraine Patients to Physiotherapy (MIGSKA)
Multicenter Interventional Study for the Evaluation of the Performance of the Doraldo-Castelletti Scale in Supporting the Neurologist's Decision to Refer Migraine Patients to Physiotherapy (MIGSKA)
Migraine is the leading cause of disability worldwide among people aged 15 to 49. Although therapies targeting the CGRP pathway have improved the management of the condition, there are large groups of patients who do not respond to medications or for whom these are contraindicated. In this context, non-pharmacological therapies such as physical therapy play a crucial role.
The scientific literature highlights a strong link between migraine and cervical disorders:
- 77% of migraine patients suffer from neck pain.
- 93% have at least three musculoskeletal dysfunctions in the cervical region.
- Patients with cervical symptoms experience more frequent attacks, greater disability, a poorer response to medication, and a higher risk of chronicity.
Despite the proven utility of physical therapy for the prevention and treatment of migraine (as demonstrated by validated physical tests and standardized questionnaires such as the NDI, HDI, and HIT-6), musculoskeletal screening is not routinely included in neurological examinations. Neurologists in headache centers generally lack the time and specific manual skills required to perform a thorough physical assessment of the cervical spine.
There is therefore a lack of a rapid and effective screening tool that serves as a "bridge" between neurology and rehabilitation.
The primary objective of the MIGSKA study is to evaluate the performance of the Doraldo-Castelletti scale in assessing the clinical need and motivation of patients with migraine to undergo physical therapy. The study will also assess the utility of this scale as a decision-making tool for neurologists in referring appropriate patients to physical therapists.
To address this gap in clinical practice, the study analyzes the Doraldo-Castelletti scale. The adoption of this tool aims to:
- Easily identify migraine patients with significant musculoskeletal dysfunction.
- Quantify the patient's attitude and motivation toward manual therapy (a determining factor for treatment success).
- Provide the neurologist with an objective and rapid criterion for prescribing a specialized physical therapy evaluation, promoting a genuine and effective multidisciplinary approach to migraine care.
研究概览
详细说明
Migraine is the leading cause of disability worldwide among people aged 15 to 49. Although therapies targeting the CGRP pathway have improved the management of the condition, there are large groups of patients who do not respond to medications or for whom these are contraindicated. In this context, non-pharmacological therapies such as physical therapy play a crucial role.
The scientific literature highlights a strong link between migraine and cervical disorders:
- 77% of migraine patients suffer from neck pain.
- 93% have at least three musculoskeletal dysfunctions in the cervical region.
- Patients with cervical symptoms experience more frequent attacks, greater disability, a poorer response to medication, and a higher risk of chronicity.
Despite the proven utility of physical therapy for the prevention and treatment of migraine (as demonstrated by validated physical tests and standardized questionnaires such as the NDI, HDI, and HIT-6), musculoskeletal screening is not routinely included in neurological examinations. Neurologists in headache centers generally lack the time and specific manual skills required to perform a thorough physical assessment of the cervical spine.
There is therefore a lack of a rapid and effective screening tool that serves as a "bridge" between neurology and rehabilitation.
The primary objective of the MIGSKA study is to evaluate the performance of the Doraldo-Castelletti scale in assessing the clinical need and motivation of patients with migraine to undergo physical therapy. The study will also assess the utility of this scale as a decision-making tool for neurologists in referring appropriate patients to physical therapists.
To address this gap in clinical practice, the study analyzes the Doraldo-Castelletti scale. The adoption of this tool aims to:
- Easily identify migraine patients with significant musculoskeletal dysfunction.
- Quantify the patient's attitude and motivation toward manual therapy (a determining factor for treatment success).
- Provide the neurologist with an objective and rapid criterion for prescribing a specialized physical therapy evaluation, promoting a genuine and effective multidisciplinary approach to migraine care.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Alberto Doretti, MD
- 电话号码:2937 +39-0261911
- 邮箱:a.doretti@auxologico.it
研究联系人备份
- 姓名:Luca G Grappiolo
- 电话号码:2894 +39-0261911
- 邮箱:luca.grappiolo@auxologico.it
学习地点
-
-
-
Milan、意大利、20149
- 招聘中
- Istituto Auxologico Italiano
-
接触:
- Alberto Doretti, MD
- 电话号码:2937 +39-0261911
- 邮箱:a.doretti@auxologico.it
-
接触:
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age between 18 and 70 years (inclusive)
- Diagnosis of migraine established by a neurologist specialized in headache disorders
- Headache Impact Test (HIT-6) ≥ 42
- Ability to understand the study informed consent
- Signed informed consent
- Ability to comply with the study procedures
Exclusion Criteria:
- Neurological diseases confounding the primary objective
- Conditions confounding the primary objective (e.g., fibromyalgia, which could limit patient evaluation by the physiotherapist)
- Previous physiotherapy treatments specifically for headache management
- Psychiatric disorders confounding and/or interfering with the primary objective
- Unstable psychiatric illness, cognitive impairment, dementia, or substance abuse compromising the participant's ability to provide informed consent, according to the investigator's judgment
- Previous neurosurgical interventions involving the cervical region
- Any condition deemed contraindicating study participation according to the investigator's judgment
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Doraldo Castelletti scale
Migraine patients are the targeted population for administration of the Doraldo-Castelletti scale during a neurological visit
|
During a routine neurological examination, the physician administers the Doraldo-Castelletti scale to the migraine patient.
The scale consists of 10 multiple choice questions.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Score of the Doraldo-Castelletti scale
大体时间:At baseline
|
Scale consisting of 10 multiple choice questions; Minimum score = 0; Maximum score = 13
|
At baseline
|
|
Proportion of patients referred to physiotherapist
大体时间:At baseline
|
Proportion of patients referred to physiotherapist on the basis of the score of the Doraldo-Castelletti scale
|
At baseline
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Doraldo-Castelletti scale的临床试验
-
NEUROPHETAjou University Hospital, Suwon, South Korea完全的